Related Experiment Video
Updated: Jun 25, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Dissemination and growth of cancer cells in metastatic sites
Ann F Chambers1, Alan C Groom, Ian C MacDonald
1London Regional Cancer Centre, London, Ontario N6A 4L6, Canada. ann.chambers@lrcc.on.ca
Abstract:
Metastases, rather than primary tumours, are responsible for most cancer deaths. To prevent these deaths, improved ways to treat metastatic disease are needed. Blood flow and other mechanical factors influence the delivery of cancer cells to specific organs, whereas molecular interactions between the cancer cells and the new organ influence the probability that the cells will grow there. Inhibition of the growth of metastases in secondary sites offers a promising approach for cancer therapy.
Insights
Metastases cause most cancer deaths, necessitating better treatments. Targeting the growth of secondary tumors offers a promising therapeutic strategy to improve patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Metastases, the spread of cancer from the primary site, are the leading cause of cancer-related mortality.
- Current therapeutic strategies often focus on primary tumor control, with less emphasis on managing established metastatic disease.
Purpose of the Study:
- To highlight the critical role of metastases in cancer-induced mortality.
- To explore the biological and mechanical factors governing cancer cell dissemination and secondary tumor formation.
- To underscore the therapeutic potential of inhibiting metastatic growth in secondary sites.
Main Methods:
- Review and synthesis of existing research on cancer cell metastasis.
- Analysis of factors influencing cancer cell transport via blood flow and mechanical forces.
- Examination of molecular interactions critical for secondary tumor establishment and growth.
Main Results:
- Cancer cell delivery to organs is influenced by hemodynamic and mechanical factors.
- Successful metastasis outgrowth depends on specific molecular interactions between cancer cells and the secondary organ microenvironment.
- Inhibiting metastatic growth presents a viable therapeutic avenue.
Conclusions:
- Effective cancer treatment must address metastatic disease to reduce mortality.
- Understanding the mechanisms of metastasis can lead to novel therapeutic targets.
- Inhibiting the growth of secondary tumors is a promising strategy for improving cancer patient survival.
Related Concept Videos
Cancer
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

